January 19, 2025 - 22:11

Investors brace for a volatile ride as President-elect Donald Trump’s second term gets underway on Monday, bringing the promise of significant policy shifts. Market analysts are closely examining which sectors may emerge as winners and losers under the incoming administration.
Historically, Trump's policies have had a profound impact on various industries, with energy, defense, and financial sectors often benefiting from his administration's initiatives. The anticipated focus on deregulation and tax cuts is expected to give a boost to these areas, attracting investor interest. Conversely, sectors such as technology and healthcare may face headwinds due to potential regulatory changes and shifts in trade policies.
As the new term unfolds, investors are advised to stay alert and agile, ready to adapt their strategies in response to the unfolding political landscape. The uncertainty surrounding Trump's agenda, combined with the ongoing economic recovery, suggests that volatility will be a defining feature of the markets in the coming months.
July 27, 2026 - 01:41
A $25,000 home repair could wipe out her $27,000 emergency fund — experts say there's a smarter moveA single home repair can put a serious dent in your savings. One homeowner recently faced a $25,000 repair bill that would have nearly wiped out her $27,000 emergency fund. While using that cash...
July 26, 2026 - 01:04
Cimpress Stock Faces Valuation Concerns Despite Recent GainsCimpress stock has seen impressive growth, nearly doubling in value over the past year. However, this rise brings attention to its current valuation, which appears to be on the high side. With a...
July 25, 2026 - 23:26
LPL Financial Expands Wealth Services Amid Legal ChallengesLPL Financial LLC has recently expanded its offerings by incorporating HighWater Wealth and Williams Tax & Financial Services into its broker-dealer and registered investment advisor platform. This...
July 25, 2026 - 01:33
Scribe Therapeutics Inc. Stock InsightsInvestors looking for insights into Scribe Therapeutics Inc. will find a wealth of information available. The company is making strides in the biotech industry, focusing on gene editing...